X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9103) 9103
Newsletter (190) 190
Book Chapter (47) 47
Newspaper Article (42) 42
Transcript (12) 12
Magazine Article (6) 6
Publication (5) 5
Book / eBook (4) 4
Dissertation (4) 4
Conference Proceeding (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6460) 6460
atrial fibrillation (4372) 4372
male (3791) 3791
female (3383) 3383
cardiac & cardiovascular systems (2954) 2954
atrial-fibrillation (2688) 2688
middle aged (2529) 2529
animals (2494) 2494
aged (2490) 2490
risk factors (1730) 1730
heart (1272) 1272
cardiac arrhythmia (1219) 1219
stroke (1219) 1219
adult (1206) 1206
atrial fibrillation - drug therapy (1198) 1198
atrial fibrillation - metabolism (1188) 1188
atrial fibrillation - physiopathology (1185) 1185
pharmacology & pharmacy (1138) 1138
fibrillation (1122) 1122
warfarin (985) 985
risk (953) 953
heart failure (934) 934
cardiology (922) 922
anticoagulants (920) 920
cardiovascular (911) 911
analysis (866) 866
peripheral vascular disease (863) 863
mortality (861) 861
research (808) 808
aged, 80 and over (798) 798
atrial fibrillation - complications (755) 755
care and treatment (751) 751
heart-failure (747) 747
prevention (726) 726
treatment outcome (719) 719
electrocardiography (690) 690
arrhythmia (678) 678
atrial fibrillation - etiology (664) 664
medicine & public health (662) 662
atrial fibrillation - blood (631) 631
heart atria - metabolism (629) 629
anticoagulants - therapeutic use (628) 628
hypertension (628) 628
cardiovascular disease (623) 623
cardiovascular diseases (603) 603
time factors (596) 596
myocardium - metabolism (594) 594
myocytes, cardiac - metabolism (577) 577
hematology (568) 568
abridged index medicus (559) 559
endocrinology & metabolism (545) 545
inflammation (533) 533
expression (532) 532
health aspects (530) 530
mice (521) 521
physiology (515) 515
administration, oral (490) 490
patients (487) 487
medical research (486) 486
prospective studies (486) 486
medicine, general & internal (482) 482
disease (480) 480
fibrosis (480) 480
internal medicine (477) 477
biomarkers - blood (475) 475
atrial fibrillation - genetics (469) 469
cell biology (467) 467
heart diseases (467) 467
anticoagulants - administration & dosage (463) 463
prognosis (459) 459
drug therapy (458) 458
rats (451) 451
disease models, animal (446) 446
management (439) 439
medicine (439) 439
anticoagulants - adverse effects (437) 437
atrial fibrillation - diagnosis (435) 435
dabigatran (434) 434
diabetes (434) 434
dogs (434) 434
oxidative stress (434) 434
atrial fibrillation - pathology (433) 433
stroke - prevention & control (431) 431
physiological aspects (427) 427
atrial fibrillation - epidemiology (426) 426
proteins (423) 423
therapy (421) 421
cardiovascular system (416) 416
myocardial-infarction (416) 416
medicine, experimental (411) 411
c-reactive protein (409) 409
heart atria - physiopathology (408) 408
surgery (408) 408
prevalence (404) 404
mechanisms (402) 402
medicine, research & experimental (394) 394
thromboembolism (392) 392
studies (391) 391
arrhythmias (386) 386
risk assessment (386) 386
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9181) 9181
Japanese (73) 73
Chinese (66) 66
Russian (58) 58
German (46) 46
French (24) 24
Spanish (21) 21
Polish (12) 12
Portuguese (9) 9
Italian (8) 8
Korean (4) 4
Hungarian (3) 3
Czech (2) 2
Dutch (2) 2
Romanian (2) 2
Slovak (2) 2
Swedish (2) 2
Turkish (2) 2
Ukrainian (2) 2
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CIRCULATION, ISSN 0009-7322, 05/2012, Volume 125, Issue 17, pp. 2059 - U98
... (SR) Ca2+ leak can promote atrial fibrillation (AF). The mechanisms leading to delayed afterdepolarizations in AF patients have not been... 
ACTION-POTENTIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | CONTRACTILE DYSFUNCTION | HEART-FAILURE | DOWN-REGULATION | CARDIAC RYANODINE RECEPTOR | FKBP12.6 DEFICIENCY | sarcoplasmic reticulum | ryanodine receptor calcium release channel | CALCIUM-HANDLING ABNORMALITIES | atrial fibrillation | sodium-calcium exchanger | ADENOSINE A(2A) RECEPTORS | RECTIFIER POTASSIUM CURRENT | delayed afterdepolarizations | PERIPHERAL VASCULAR DISEASE | RAT VENTRICULAR MYOCYTES | Phosphorylation | Calcium - metabolism | Humans | Male | Ryanodine Receptor Calcium Release Channel - metabolism | Atrial Fibrillation - physiopathology | Recombinant Fusion Proteins - metabolism | Action Potentials | Biological Transport, Active | Lipid Bilayers | Caffeine - pharmacology | Female | Sarcoplasmic Reticulum - metabolism | Calcium-Calmodulin-Dependent Protein Kinase Type 2 - metabolism | Sarcoplasmic Reticulum Calcium-Transporting ATPases - metabolism | Calmodulin - metabolism | Sodium-Calcium Exchanger - physiology | Sulfonamides - pharmacology | Gene Knock-In Techniques | Atrial Fibrillation - metabolism | Patch-Clamp Techniques | Animals | Membrane Potentials | Ryanodine Receptor Calcium Release Channel - genetics | Myocytes, Cardiac - physiology | Aged | Mice | Protein Processing, Post-Translational | Benzylamines - pharmacology | Chronic Disease | Measurement | Research | Sarcoplasmic reticulum | Atrial fibrillation | Tetracaine | ryanodine receptor | Na+-Ca2+-exchanger | sarcoplasmic reticulum Ca2+-leak
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2018, Volume 138, Issue 20, pp. 2227 - 2242
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2014, Volume 129, Issue 12, pp. 1276 - 1285
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2015, Volume 83, pp. 88 - 100
Journal Article
Journal Article
Heart Rhythm, ISSN 1547-5271, 2013, Volume 10, Issue 7, pp. 1001 - 1009
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 02/2014, Volume 129, Issue 6, pp. 625 - 634
BACKGROUND—High-sensitivity troponin-I (hs-TnI) measurement improves risk assessment for cardiovascular events in many clinical settings, but the added value in atrial fibrillation patients has not been... 
Troponin | Biological markers | Cardiovascular diseases | Atrial fibrillation | Risk assessment | MORTALITY | risk assessment | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | cardiovascular diseases | T ASSAY | atrial fibrillation | IMPACT | troponin | WARFARIN | biological markers | PERIPHERAL VASCULAR DISEASE | ASSOCIATION | Risk Assessment - methods | Anticoagulants - administration & dosage | Humans | Middle Aged | Hemorrhage - mortality | Warfarin - adverse effects | Male | Warfarin - administration & dosage | Incidence | Troponin I - blood | Fibrinolytic Agents - adverse effects | Pyridones - administration & dosage | Thromboembolism - prevention & control | Atrial Fibrillation - mortality | Sensitivity and Specificity | Female | Stroke - mortality | Atrial Fibrillation - diagnosis | Pyrazoles - adverse effects | Stroke - prevention & control | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Treatment Outcome | Thromboembolism - mortality | Anticoagulants - adverse effects | Atrial Fibrillation - metabolism | Pyrazoles - administration & dosage | Death | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Pyridones - adverse effects | Stroke (Disease) | Evaluation | Care and treatment | Control | Apixaban
Journal Article